Tags » Pharmaceuticals

Canntab and Emblem Announce Positive Results on Testing: Proceeding to Clinical Trials

Toronto, Ontario–(Newsfile Corp. – September 18, 2018) – Canntab Therapeutics Limited (CSE: PILL) (“Canntab” or the “Company“), today announced the achievement of a milestone with regards to the development of a patent-pending oral extended release formulation for cannabinoids in collaboration with Emblem Corp. 877 more words

Global Scar Removal Treatment Market By Sales, Consumption, Demand and Forecast 2018-2023

This report focuses on the Scar Removal Treatment Market by Manufacturers, Regions, Type and Application, exclusively in North America, Europe and Asia-Pacific, South America, Middle East and Africa. 776 more words


Decoquinate-Based Products Market Segmentation By Recent Trends And Growth Forecast To 2025

Decoquinate (ethyl 6-decoxy-7-ethoxy-4-oxo-1H-quinoline-3-carboxylate) is an antiprotozoal agent. It acts against coccidia parasites and is thus known as a coccidiostat. Decoquinate-based products are majorly used in veterinary medicine. 497 more words


Enzyme Inhibitor Market Share by Manufacturers, Supplier, Region and Distributor Analysis up to 2022

18th September: The Enzyme Inhibitor Market is expected to witness growth owing to the growth of pharmaceutical drug industry. The key driver of this industry is the global spending on medicines in coalition with the increasing demand of specialty drugs. 528 more words


Antihypertensive Drugs Market 2025 Research Report In-Depth Analysis by Current Trends, High Demand and Risk

18th September, 2018 – Antihypertensive Drugs Market is observing random and spectacular growth at a high CAGR in forthcoming period. Hypertension is an undesirable medical condition whereby blood level rises to inordinately high levels and is characterized by primary hypertension and secondary hypertension. 279 more words

United States TNF Inhibitors Market Product, Application, End-User Industry, and Geography - Global Forecast to 2025

18th September 2018 – United States TNF (Tumor Necrosis Factor) Inhibitors Market is expected to grow at the highest CAGR in the upcoming years. TNF is better known as “tumor necrosis factor” inhibitor and is anti-inflammatory drug. 433 more words


Therma Bright Adds Strategic Advisor, Too Jae Min, Professor, Department of Anesthesiology and Pain Medicine, Korea University

Toronto, Ontario–(Newsfile Corp. – September 17, 2018) – Therma Bright Inc. (TSXV: THRM), (“Therma Bright”, “Therma”, or the “Company”- formerly The Jenex Corporation), a progressive medical device technology company, today is pleased to announce the appointment of Dr. 953 more words